This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Prefilled Syringes To 2018 - Devices, Drugs, Markets, Players And Prospects

Demand Drivers

Drug Discovery and Development Trends

Patient and Caregiver Sentiment

Diseases and Indications

Patient Demographics

The Prefilled Syringe Ecosystem and Supply Chain

Materials and Components

Evolving Technology

Alliances & Relationships

Syringe Manufacturers

Technology/Capabilities

Geographic Reach

Barriers to Entry

CMO's – Beyond Fill & Finish

Value-added Services

Market Proximity

CMO Evolution

Testing, Services and Validation

Prefilled Syringes – Design Factors

Drug Stability and Shelf Life

Material Selection Issues

Point-of-Use Reconstitution

Caregiver Safety

Needle Configuration Strategies

Human Engineering/Ergonomics

Prefilled Syringes – Commercial Devices

Prefillable Therapeutic Injectables

Glass Prefillable Syringes

Plastic Prefillable Syringes

Ready-to-Fill Safety Syringes

Specialty Prefillable SyringesFlush SyringesDiluent SyringesImaging Agent Syringes

Competing Prefilled Devices

Bundled PFS + Autoinjector

Prefilled Pen Injectors

Prefilled Needle-free Injectors

Prefilled Syringe Market Segments

Prefilled Therapeutic Injectables

AnaphylaxisAnticoagulantsAutoimmune DiseasesEmergency MedicineHepatitisHematopoietics and Related Erythropoiesis Stimulating ProteinsMetabolic Diseases NeurologyReproductive HealthVaccines?Non-API Prefilled Syringe Segments

Catheterization

Reconstitution

Diagnostic Imaging?

Market Factors

Self-Administration and Patient Compliance

Insurance, Reimbursement, and Managed Care

Regulatory Guidance and Product Approvals

The Evolving PFS Ecosystem

Prefilled Syringes – Market Participant Profiles

To order this report: Drug_Delivery_Technology Industry: Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects



Contact Clare: clare@reportlinker.com

US:(339) 368 6001

Intl:+1 339 368 6001



SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,083.80 -2.83 -0.02%
S&P 500 1,987.98 +0.97 0.05%
NASDAQ 4,472.1080 -1.5890 -0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs